Birch Allergy Treatment Market

Birch allergy treatment sales will grow through 2036, led by antihistamines at 48.9% of the drug class in 2026. The market was valued at USD 653.77 million in 2025 and is expected to be worth USD 1,376.03 million by 2036, creating an incremental opportunity of USD 676.52 million.